Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuo Shimada

Showing results (561-570 of 672) with videos related to

Pageof 68
Sort By:
Oncology Reports|June 18, 2002
Morphologic approach to hepatocellular carcinoma development in man: de novo or the so-called 'dysplastic nodule-carcinoma' sequence?Ken-Ichi Taguchi, Yoshiki Asayama, Shin-Ichi Aishima, et al.
Annals of Surgery|November 21, 2013
A pancreaticoduodenectomy risk model derived from 8575 cases from a national single-race population (Japanese) using a web-based data entry system: the 30-day and in-hospital mortality rates for pancreaticoduodenectomyWataru Kimura, Hiroaki Miyata, Mitsukazu Gotoh, et al.
Annals of Surgery|July 30, 2014
A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patientsTohru Utsunomiya, Mitsuo Shimada, Masatoshi Kudo, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|September 19, 2022
Muscle strength is a stronger prognostic factor than muscle mass in patients with gastrointestinal and hepatobiliary pancreatic cancersNanami Nasu, Sonoko Yasui-Yamada, Natsumi Kagiya, et al.
Surgery Today|April 29, 2019
Antimicrobial prophylaxis for 1 day versus 3 days in liver cancer surgery: a randomized controlled non-inferiority trialTadatoshi Takayama, Osamu Aramaki, Taro Shibata, et al.
Surgical Endoscopy|January 9, 2014
Characteristics of internal hernia after gastrectomy with Roux-en-Y reconstruction for gastric cancerKozo Yoshikawa, Mitsuo Shimada, Nobuhiro Kurita, et al.
Clinical Transplantation|December 21, 2010
Pancreatic complications following orthotopic liver transplantationKatsuhiko Yanaga, Mitsuo Shimada, Robert D Gordon, et al.
JCO Precision Oncology|December 16, 2021
Circulating miRNA Signature Predicts Response to Preoperative Chemoradiotherapy in Locally Advanced Rectal CancerYuma Wada, Mitsuo Shimada, Yuji Morine, et al.
Anticancer Research|November 10, 2019
Carbohydrate Antigen 19-9 Is a Prognostic Factor Which Correlates With HDAC1 and HIF-1α for Intrahepatic CholangiocarcinomaShogo Ohta, Yuji Morine, Satoru Imura, et al.
Anticancer Research|December 27, 2017
The Outcome of Sorafenib Therapy on Unresectable Hepatocellular Carcinoma: Experience of Conversion and Salvage HepatectomyToshiaki Yoshimoto, Satoru Imura, Yuji Morine, et al.
Pageof 68

Showing results (561-570 of 672) with videos related to

Sort By:
Pageof 68
Oncology Reports|June 18, 2002
Morphologic approach to hepatocellular carcinoma development in man: de novo or the so-called 'dysplastic nodule-carcinoma' sequence?Ken-Ichi Taguchi, Yoshiki Asayama, Shin-Ichi Aishima, et al.
Annals of Surgery|November 21, 2013
A pancreaticoduodenectomy risk model derived from 8575 cases from a national single-race population (Japanese) using a web-based data entry system: the 30-day and in-hospital mortality rates for pancreaticoduodenectomyWataru Kimura, Hiroaki Miyata, Mitsukazu Gotoh, et al.
Annals of Surgery|July 30, 2014
A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patientsTohru Utsunomiya, Mitsuo Shimada, Masatoshi Kudo, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|September 19, 2022
Muscle strength is a stronger prognostic factor than muscle mass in patients with gastrointestinal and hepatobiliary pancreatic cancersNanami Nasu, Sonoko Yasui-Yamada, Natsumi Kagiya, et al.
Surgery Today|April 29, 2019
Antimicrobial prophylaxis for 1 day versus 3 days in liver cancer surgery: a randomized controlled non-inferiority trialTadatoshi Takayama, Osamu Aramaki, Taro Shibata, et al.
Surgical Endoscopy|January 9, 2014
Characteristics of internal hernia after gastrectomy with Roux-en-Y reconstruction for gastric cancerKozo Yoshikawa, Mitsuo Shimada, Nobuhiro Kurita, et al.
Clinical Transplantation|December 21, 2010
Pancreatic complications following orthotopic liver transplantationKatsuhiko Yanaga, Mitsuo Shimada, Robert D Gordon, et al.
JCO Precision Oncology|December 16, 2021
Circulating miRNA Signature Predicts Response to Preoperative Chemoradiotherapy in Locally Advanced Rectal CancerYuma Wada, Mitsuo Shimada, Yuji Morine, et al.
Anticancer Research|November 10, 2019
Carbohydrate Antigen 19-9 Is a Prognostic Factor Which Correlates With HDAC1 and HIF-1α for Intrahepatic CholangiocarcinomaShogo Ohta, Yuji Morine, Satoru Imura, et al.
Anticancer Research|December 27, 2017
The Outcome of Sorafenib Therapy on Unresectable Hepatocellular Carcinoma: Experience of Conversion and Salvage HepatectomyToshiaki Yoshimoto, Satoru Imura, Yuji Morine, et al.
Pageof 68